Motivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study
The importance of assessing motivations to co-use should be routinely recognised as part of harm reduction and medication assisted treatments to reduce mortality risk.
Authors
- Gabriele Vojt (ORCID: https://orcid.org/0000-0002-9135-0684)
- Matthew Hickman (ORCID: https://orcid.org/0000-0001-9700-4435)
- Joanna Kesten (ORCID: https://orcid.org/0000-0002-3674-6045)
- Jenny Scott (ORCID: https://orcid.org/0000-0002-4920-0914)
- Graeme Henderson (ORCID: https://orcid.org/0000-0001-6050-0048)
- Christopher Bailey (ORCID: https://orcid.org/0000-0003-0781-8887)
- Damiana Cavallo (ORCID: https://orcid.org/0000-0003-3985-8568)
- Sara Karimi (ORCID: https://orcid.org/0000-0002-3626-8936)
- Samantha Stewart (ORCID: https://orcid.org/0000-0002-4600-810X)
- Ana P. Abdala (ORCID: https://orcid.org/0000-0001-6566-9205)
- Hannah Poulter (ORCID: https://orcid.org/0000-0002-7256-0504)
- Hannah Family (ORCID: https://orcid.org/0000-0003-1243-778X)
- Louise Aitken
- Peter Da Silva
- Nick Booth
Institutions
- University of the West of England (GB)
- At Bristol (GB)
- Middlesbrough College (GB)
- Brunswick (United States) (US)
- National Institute for Health and Care Research (GB)
- University of Bristol (GB)
- NIHR Bristol Biomedical Research Centre (GB)
- University of Bath (GB)
- Teesside University (GB)
Publication Details
- Journal
- Harm Reduction Journal
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1186/s12954-025-01312-x
- Citations
- 2
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- Medical Research Council